Peter Nash drpnash
5 years ago
Association Between Changes in Pain Sensitization and Changes in Disease Activity After 12 Weeks of Disease Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis https://t.co/DLGFcDqrus #RA #pain Pain sensitization a management issue - disease control minor benefit
Leonard Calabrese LCalabreseDO
5 years ago
Very psyched for this session tomorrow at #ACR20 on irAEs- this was a win for Twitter big time-thnxs for the shout out!!! looking for the next cut of data from the @rheum_covid alliance !!! @RheumNow @drdavidliew @CCalabreseDO @cappelliMD @HealioRheum https://t.co/qepFdLhmlV https://t.co/1jSek0sRqT
The RECIPE Study - MMF in Refractory Gout: Dr. Jack Cush
Dr. Jack Cush previews the RECIPE study, wherein MMF is used to blunt the immunogenicity of pegloticase (abstract #0952 presented at the ACR 2020 annual meeting).
Antimalarials in Pre COVID-19 Era: Dr. Janet Pope
Dr. Pope discusses abstract #0002 presented at the #ACR20 annual meeting.
RheumNow Preview by Dr. Jack Cush
Dr. Cush previews RheumNow's ACR virtual meeting coverage, and highlights new features this year: ACR IQ and ACR chat! On ACR chat, Dr. Cush wants to know: what's the burning question? Don't forget to download the virtual ACR 2020 Playbook!
Inadequate Response in Spondylitis: Dr. Olga Petryna
Dr. Petryna discusses two abstracts being presented at the ACR 2020 meeting: #0359 and #0371.
Christina Downey, MD, RhMSUS cdowneymd
5 years ago
Happening now! Session 1T001 Opening Session of #ACR20. #ACRambassador Head on over, @ACRheum! https://t.co/eErNDB8pV6
Richard Conway RichardPAConway
5 years ago
#ACR20 year in review @JYazdanyMD CIRT trial showing that MTX pneumonitis occurs but is very (very) rare. @RheumNow @jeffsparks @DanielHSolomon https://t.co/UbD4mhHBzq
QD Clinic - Running out of Options
Difficult RA with Serious Infections and Limited options
Since the beginning of the pandemic, rheumatologists scrambled to figure out how the SARS-CoV-2 virus will affect their patients with immune mediated inflammatory diseases (IMID). Meeting the needs of patients, managing a practice, and trying to balance a home life have many doctors stressed.
There are some really interesting poster and abstract presentations on spondyloarthritis at the ACR Convergence 2020. I’ll be covering these topics, and discussing select individual posters and abstracts during this meeting.
Here is a flavour of my read through the topics that are being covered during the meeting.
Infection in the setting of autoimmune rheumatic disease (ARD) has been the subject of increasing research and clinical interest for decades. Despite the huge burden of infection in patients with ARDs, this area of research has really been catapulted to the centre-stage of research agendas and coverage at congresses, including ACR 2020, with the arrival of the coronavirus disease 2019 (COVID-19) pandemic.
Virtual ACR Experience Panel: Drs. David Liew, Richard Conway, Sheila Reyes, Swamy Venuturupalli.
Dr. David Liew interviews rheumatologists from around the world about the upcoming ACR 20 virtual annual meeting. Guests include Dr. Swamy Venuturupalli, Chair of ACR's Committee on Education, Dr. Richard Conway from Dublin, Ireland, and Dr. Sheila Reyes from Rizal, Philippines.
Axial Involvement in Psoriatic Arthritis: Dr. Eric Ruderman Perspective
Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis. During his remarks, he discusses ACR abstracts #0344, #1372, #2025 and #0505.
Non-radiographic axSpa ACR Abstracts: Dr. Rachel Tate
Dr. Rachel Tate discusses abstracts #0876 and #0448 presented at the ACR20 annual meeting.
Poster Hall